Driving After Spravato or Ketamine Treatment: Safety Guidelines & Why You Can't
Following ketamine or esketamine, you cannot drive, operate heavy machinery, or engage in tasks requiring complex motor coordination until the next day. The medicine can impact reaction time - the effects of which could pose a risk to yourself and others. This safety protocol protects you during the post-treatment window while acute neuro-cognitive effects fully resolve.
The Pharmacological Reasons Behind Post-Session Regulations
To understand these regulations, it is helpful to look at the underlying neurobiology. Spravato is FDA-approved for adults with treatment-resistant depression and major depression with suicidal thoughts.[1] The active molecule, esketamine, is the S-enantiomer of ketamine — one of its two mirror-image forms, and the one that binds the NMDA receptor more strongly.
When introduced to the system, the medicine's primary mechanism of action is thought to primarily impact an excitatory chemical in the brain called glutamate, triggering a cascade that aims to reduce depressive symptoms.[2] However, this same pharmacological action acutely alters proprioception, spatial awareness, and reaction times. The brain is entering a biologically receptive window for change, but during the immediate two hours post-administration, cognitive and motor faculties are impacted. The same glutamate-system effects that open a window for change also temporarily affect alertness, coordination and reaction time, as does the sedation the medicine causes. That is the primary reason why treatment centers, like Lumin Health, engage in treatment only once a person agrees to avoid driving for the remainder of the day after treatment.
How Lumin Health Prioritizes Your Physical Safety
At Lumin Health, we view the required clinical protocol not as an inconvenience, but as a critical component of your care protocol. Our academically-affiliated leadership understands that achieving relief requires self-guided intent, but it also requires an environment of safety.
"The restriction on driving is not merely a bureaucratic hurdle – it is a medical necessity protecting the delicate transition back to baseline. All treatment starts with safety, and not only the safety generated when our staff members and the people we get to see are closely aligned, but also the nuts and bolts safety of making sure that the logistics of care are appropriately tuned to risk." – Dr. Ben Yudkoff, Chief Medical Officer at Lumin Health.
Step-by-Step: The Departure Protocol
The logistical requirements for your departure are maintained to ensure clinical safety. Here is what to expect during your evaluation and subsequent appointments:
- Observation Period: You will remain in our comfortable, monitored environment for a minimum of two hours while vital signs are tracked.
- Medical Clearance: A provider assesses your cognitive baseline, ensuring dizziness, dissociation, and blood pressure changes have fully resolved.
- Arranged Transport: We make sure that you have a safe way home.
- Rest Phase: When getting home, we suggest activities to further decompress and take stock of the experience you just had.
Translating These Rules to Intramuscular Applications
While esketamine is bound by specific Risk Evaluation and Mitigation Strategy protocols, we map the same approach to off-label use of ketamine, such as ketamine for depression.
At Lumin Health, our practice favors IM delivery because it offers a smoother, more comfortable experience compared to a slow intravenous infusion, yet the side effect profiles remain the same. Just as with Spravato, driving after ketamine therapy is explicitly prohibited until after a full night of restful sleep.[3]
Partnering With Your Provider for Optimal Outcomes
The period immediately following your appointment is a prime opportunity for psychotherapy or your own self-guided practice. You may find that journaling, light reading, or reflecting on your intent yields profound insights. Meaningful relief may be possible when you pair this biological window with deliberate, self-guided work.
As an organization rooted in Massachusetts but serving as a resource for those seeking clarity nationwide, we understand that coordinating transportation can be challenging. However, we have found that when you plan your travel logistics in advance, you can experience significantly less anxiety entering your sessions. Consensus guidance from the American Psychiatric Association stresses that ketamine and esketamine belong in structured, medically supervised settings, and that is the environment we build every session around.[4]
If you are exploring whether esketamine – administered via the FDA-approved Spravato protocol – or IM racemic injections may be a fit for your specific psychiatric needs, we would be grateful to walk with you towards relief. At Lumin Health, our goal is to provide a meticulously safe setting where you can focus entirely on your path to wellness.
References
- Vekhova KA, Namiot ED, Jonsson J, et al. Ketamine and Esketamine in Clinical Trials: FDA-Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations. Clin Pharmacol Ther. 2025;117(2):374-386. PubMed
- Cheng YJ, Lin CH, Lane HY. Ketamine, benzoate, and sarcosine for treating depression. Neuropharmacology. 2023;223:109351. PubMed
- McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. Am J Psychiatry. 2021;178(5):383-399. PubMed
- Sanacora G, Frye MA, McDonald W, et al. A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders. JAMA Psychiatry. 2017;74(4):399-405. PubMed
Find out if ketamine therapy is covered by your plan.
Lumin Health accepts most major insurance providers for Spravato treatment in Massachusetts and the greater Washington DC/Maryland area. Use our free tool to check your coverage instantly — no forms, no phone calls.
Available in Massachusetts and the greater Washington DC/Maryland area.
Frequently Asked Questions
Can I drive after a ketamine or Spravato session?
No. You cannot drive, operate heavy machinery, or do tasks that require complex motor coordination until the day after your session. This protects you while the medication's effects on reaction time and coordination fully resolve.
How long do you have to wait to drive after ketamine therapy?
Plan to wait until the next day, after a full night of restful sleep, before you drive. You'll first spend a minimum of two hours or more being monitored right after your session, and Lumin Health helps make sure you have a safe way home.
Why can't you drive after ketamine or Spravato treatment?
The treatment's effect on glutamate, a brain chemical involved in the medicine's mechanism, can temporarily affect your alertness, coordination, and reaction time, and the sedation adds to that effect. Waiting until you've had a full night of sleep lets these effects fully resolve.
Does the driving restriction apply to IM ketamine, not just Spravato?
Yes. The same restriction applies to IM ketamine as it does to esketamine (Spravato): no driving until after a full night of restful sleep.
